$2.54
-0.01-0.39%
At close: Nov 13, 4:00 PM EST
$2.48
-0.06-2.36%
After Hours: 7:59 PM EST
Ovid Therapeutics Inc (OVID) Stock Price, Quote, News & History
OVIDNASDAQ
Ovid Therapeutics shares climb after positive epilepsy data, new trial launch, and $60 million funding boost extending runway into 2028.
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Other companies in Ovid Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Ovid Therapeutics has a consensus price target of $4.77.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $2.48 last updated November 13, 2026 at 7:59 PM EST.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated...
